Home » Stocks » GeoVax Labs

GeoVax Labs, Inc. (GOVX)

Stock Price: $0.735 USD 0.015 (2.08%)
Updated Jul 31, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 10.17M
Revenue (ttm) 1.53M
Net Income (ttm) -2.41M
Shares Out 13.82M
EPS (ttm) -1.84
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 31, 2020
Last Price $0.735
Previous Close $0.720
Change ($) 0.015
Change (%) 2.08%
Day's Open 0.730
Day's Range 0.700 - 0.790
Day's Volume 325,292
52-Week Range 0.115 - 1.750

More Stats

Market Cap 10.17M
Enterprise Value 9.63M
Earnings Date (est) Aug 18, 2020
Ex-Dividend Date n/a
Shares Outstanding 13.82M
Float 13.09M
EPS (basic) -7.47
EPS (diluted) -1.84
FCF / Share -0.13
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 1.35
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 6.66
PB Ratio n/a
Revenue 1.53M
Operating Income -3.62M
Net Income -2.41M
Free Cash Flow -1.62M
Net Cash 538,702
Net Cash / Share 0.04
Gross Margin -48.10%
Operating Margin -237.13%
Profit Margin n/a
FCF Margin -106.28%
ROA -217.33%
ROE n/a
ROIC 182.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $0.735
Target: 10,000
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-----63.48%-9.02%-45.77%-5.5%41.36%-
Gross Profit----0.882.422.664.905.193.67
Operating Income-3.53-3.25-4.10-3.12-2.74-2.29-2.14-2.35-2.77-3.32
Net Income-2.56-2.17-3.27-2.69-2.73-2.28-2.14-2.35-2.75-3.28
Shares Outstanding0.330.
Earnings Per Share-10.00-15.00-40.00-40.00-50.00-55.00-60.00-75.00-90.00-110.00
Operating Cash Flow-1.54-1.69-1.95-2.71-2.25-1.69-2.44-0.30-2.44-1.43
Capital Expenditures----0.02-0.04-0.09--0.01--0.27
Free Cash Flow-1.54-1.69-1.95-2.72-2.29-1.78-2.44-0.32-2.44-1.70
Cash & Equivalents0.270.320.471.061.102.511.
Total Debt0.30---------
Net Cash / Debt-0.030.320.471.061.102.511.
Book Value-1.02-0.320.
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name GeoVax Labs, Inc.
Country United States
Employees 6
CEO David A. Dodd

Stock Information

Ticker Symbol GOVX
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: GOVX


GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U.S. Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; U.S. Department of Defense; Geneva Foundation; Enesi Pharma; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.